BST FREE: The Debate Over Whether to Allow Voluntary Labeling of Products as "BST Free" Not Derived from Dairy Cows Given the Milk Production Hormone BST by Dunkum, Betty L.
 
BST FREE: The Debate Over Whether to Allow Voluntary
Labeling of Products as "BST Free" Not Derived from Dairy Cows
Given the Milk Production Hormone BST
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation BST FREE: The Debate Over Whether to Allow Voluntary
Labeling of Products as "BST Free"--Not Derived from Dairy
Cows Given the Milk Production Hormone BST (1994 Third
Year Paper)
Accessed February 19, 2015 9:36:02 AM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:8846744
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-
of-use#LAAnC~4
I3ST FREE
The Debate Over Whether to A11ox~ Voluntary Labeling of Products as
lB ST Free'{Not Derived from Dairy Cows Given the Milk Production
Hormone BST
Student ID: 504 0383 10
Food and Drug Law
Harvard Law School
Professor Peter Barton Hutt
January 27, 1994
1Swdenr ID: 504 0383 10
'Fm tired of being force-fed chemicals without having agreed to them [Uni-
versity of Washington Business School Professor John] Baden can give his wife
and children BST milk. I won't give it to my cat.
{Darlene Kaiser Lynwood1
The debate over whether to label milk and other dairy products as coming from
cows injected with the milk production hormone bovine somatotropin (BST
or rBGH-recombinant bovine growth hormone) pits consumers, like Darlene
Lynwood, who see milk as that wholesome and pure liquid you give your children
against biotechnology entrepreneurs who want to move the United States into
the Twenty-rst Century. As one of the rst agricultural biotechnology products
to come to market, BST milk is seen as a test case for bioengineered foods.
The outcome of the labeling debate and the degree of public acceptance of the
product will send a message to the developers of a range of other genetically
engineered foods (including vegetables, pork, and poultry) waiting in the wings.2
BACKGROUND
Bovine somatotropin is produced using recombinant DNA technology to
replicate a hormone naturally produced in small quantities in a cow's pitu-
itary gland. Injection of a cow with synthetic BST at regular stages during
the lactation cycle, coupled with proper feeding management, can increase milk
production by ten to twenty percent. The St. Louis-based company Monsanto
has spent approximately $500 million developing BST; Monsanto's product will
be marketed under the trade name Posilac. A new animal drug application
(NADA) for Posilac was under review by the Food and Drug Administration
1Darlene Kaiser Lynwood, Milk-Production Hormone | We Must Resist
Being Force-
Fed C'hemicalAdditives in Our Food, Ti-IF SEATTLE TIMEs, Dec. 31,
1993, at B5.
2See U.S. CONGRESS, OFFICE OF TECHNOLOGY ASSESSMENT, A
NEW TECHNOLOGICAJ.
ERA FOR AMERICAN AGRICULTURE 135 (U.S. Government Printing Of-
ce, August 1992)
(estimating the timing of commercial introduction of advancing animal tech-
nologies).
I
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(FDA) for almost a decade. On November 5, 1993, the FDA approved the
NADA for Posilac.3 Following a ninety-day moratorium passed by Congress last
August,4 BST sales will begin on February 4, 1994.
LABELING OPTIONS
The available approaches to BST-free labeling include:
a) Mandatory Labeling: All dairy products would be labeled whether
or not they contained BST.
b) n'oluntary Labeling: The FDA would police operations to en-
sure compliance under current regulations governing misbranding.5 The FDA
could also impose new regulations requiring that processors and producers who
voluntarily choose to make 'BST free' claims be licensed or certied.
c) Mandated Nondisclosure: BST free claims would be banned from
products.
The FDA considered whether to mandate BST labeling, holding a series of
hearings in May, 1993, on the issue. In the debate, opponents of mandatory BST
labeling argued that the FDA did not have the statutory authority to mandate
labeling of dairy products as being from BST-treated cows.6 This argument
carried the day.7 In
-'See HI-IS NEwS P93-40, BST (U S Department of Health and Human
Services, Washington, D.C.), Nov. 5, 1993.
4See Omnibus Budget Reconciliation Act of 1993, Pub. L. No. 103-66, x
1105(c), 107 Stat. 312 (1993).
5Sections 403(a) and 201(n) of the Food, Drug, and Cosmetic Act, 21 U.S.C.
xx 343, 321 (1988), govern misbranding. Section 403(a) states that a food is
misbranded [ijf its labeling is false or misleading in any particular, 21 U.S.C. x
343 (1988). In determining whether a label is misleading, Section 201(n) requires
the FDA to take into account not only representations about the product, but
also the extent to which the label fails to reveal facts material in the light of
such representations, or material with respect to consequences which may result
from the use of the food, 21 U.S.C. x 321 (1988). 6For a discussion of FDA's
statutory authority to mandate labeling, see OFFICE OF MANAGEMENT ~i~r
BUDGET, TIn3 USE OF Bovm~E SOMATOTROPIN (BST) IN ThE UNITED
STATES: ITS POTENTIAL EFFECTS 16-17 (January 1994) (not-
ing that, in the past, the FDA
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approving BST, the FDA agreed that it did not have the statutory authority
to mandate labeling of dairy products as being from BST-treated cows.8
The FDA did allow voluntary labeling of BST-free products, provided the
information is truthfril and not misleading '~ The FDA has not yet oered
guidelines as to what a BST free' label should say to avoid a charge of being
misbranded but is currently actively engaged in that evaluation. 10
During this evaluation, the FDA should examine whether voluntary label-
ing is the proper compromise in this case The May, 1993, hearings focused on
mandatory labeling and did not address the issue of voluntary labeling versus
mandated nondisclosure. 11 Although the FDA permits voluntary avoidance
claims{such as 7-Up's Never had it [caeine], never will claim{BST is a unique
product; strong arguments can be made that the FDA should ban BST free
claims. The issues that arise in the voluntary labeling
has declined to mandate warning statements on food labels except in specic
instances where there is scientically-based evidence of a potential health haz-
ard; since available data indicates there are no adverse health consequences from
BST, labeling is not required). See also Memorandum from King & Spalding to
the Food and Drug Administration (May, 1993) (on le with author) [hereinafter
King] (giving additional arguments that the FDA has no statutory authority to
mandate BST labeling under the ingredient listing or common or usual name
provisions of the Food, Drug, and Cosmetic Act).
7See Letter from Richard A. Merrill. Special Counsel, Covington & Burling,
to David Kessler, Commissioner, Food and Drug Administration 4 (May 25,
1993) (on le with author) [hereinafter Merrill Letter] (I note in passing that
many witnesses who favor labeling did not trouble to discuss the question of the
agency's legal authority { with good reason.).
81-H-IS NEWs, supra note 3, at I (noting that FDA Commissioner KessJer
said, [B ST] has been one of the most extensively studied animal drug products
to be reviewed by the agency. The public can be condent that milk and meat
from bST-treated cows is safe to consume.).
91d. at 3.
10Letter from Linda A. Suydam, Associate Commissioner for Operations,
Food and Drug Administration, to Alan T. Tracy, Secretary, State of Wisconsin,
Department of Agriculture, Trade and Consumer Protection 1 (Jan. 7, 1994)
(on le with author). 'See King, supra note 6, at 3 n. I (noting that voluntary
labeling presents a dierent set of legal and practical issues, which are only
touched on incidentally in this memorandum, prepared for the FDA hearings).
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versus mandated nondisclosure debate include: a) misleading claims, b) en-
forcement, c) label clutter, d) the consumers' right to know, e) eect of labeling
on consumer acceptance, and f) economic eects and U.S. competitiveness.
THE DEBATE OVER VOLUNTARY LABELING VERSUS MAN-
DATED NONDISCLOSURE
Misleading Claims
Since the Food, Drug, and Cosmetic Act focuses on whether a claim is
misleading.12 accurate statements on labels are protected. The issue of whether
a BST free claim can ever be accurate arises. Supporters of voluntary BST
labeling say there is nothing false or misleading about a BST free claim when
the cows were not injected with the hormone. Just as products can say caeine
free, fat free, or cholesterol free, producers should be allowed to say B ST free.
Those who oppose voluntary BST labeling argue that a BST free claim is
inherently misleading, because it wrongly implies there's less BST in BST-free
milk or that BST aects the character, quality or safety of milk. 13 Products
with no caeine, fat, or cholesterol are dierent from their counterparts with
caeine, fat, or cholesterol. However, the BST level in milk of treated cows is
indistinguishable from the traces (2 to 10 parts per billion) generally found in
the milk of untreated cows; there is no less BST in BST free milk. 14 Whereas
caeine, fat, and cholesterol levels can aect health, humans have been exposed
to these BST levels with no consequences.15 In addition, BST milk
12See Food, Drug, & Cosmetic Act, supra note 5.
13Merrill Letter, supra note 7, at 9.
14RALPII M. Cium, BOvINE SOMATOTROPIN (BST OR BGH): QUES-
TiONS AND ANSWERS ON A NEW DAIRY TECHNOLOGY 2 (Congres-
sional Research Service, The Library of Congress, Report No. 93-1041 ENR,
1993).
151d (noting that BST is broken down in the human gastrointestinal tract,
where it becomes inactive, and that BST is species specic: even when injected
into a human, it produces no response).
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has the same nutritional value and composition as milk from untreated cows.
16 Monsanto executives argue that the FDA should not create an articial
distinction between like foods, because this creates a perceived risk where none
exists. 17
Those who support voluntary BST labeling argue that BST-free milk is safer.
Use of synthetic BST will cause increased incidence of mastitis{an infection of
the bovine udder that occurs more frequently in high-producing cows. This
would lead to increased antibiotic residues in milk.
BST labeling opponents argue that adequate safeguards are in place to pre-
vent unsafe levels of antibiotic residues from entering the milk supply.18 In
particular, farmers must destroy milk from any dairy cow being treated with
antibiotics. If any antibiotics are found at the processing plant, the milk is
destroyed. Oending dairy farmers lose income from sale of the entire shipment
of milk, and are prohibited from marketing milk for a specic number of 19 In
addition, Monsanto has agreed to take additional actions to ensure that any
unsafe residues in BST milk are detected well before the milk or its products
reach the grocery shelves.20
Enforcement
Those who oppose voluntary BST labeling contend that enforcement prob-
lems would lead to a large number of fraudulent BST free claims. There is no
way to test milk to determine if it comes from a cow treated with BST. The
only way to prove a label is false would be to trace the milk to the individual
cows. Given the degree to which milk from numerous farms is mixed, the only
way to guarantee a B ST-free milk supply would
I 61~
17Linda Gasparello, BS1' Labeling Would Reverse Food Labeling Reform,
May Mislead
C'onsumers, Industry Tells FDA, FooD & DRINK DAILY, May 7, 1993, at 1
I 8HHS NEWs, supra note 3, at 1.
19Cilm, supra note 14, at 3.
20HH5 NEWS, supra note 3, at 2.
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be to have a dedicated supply of BST-free cows whose milk you would isolate
at all stages of processing{from the farm to the processing plant to the manu-
facturer. Unlike other product claims, such as caeine free, where you can test
the nished product to see if the label's claim is accurate, testing the accuracy
of a BST free claim means that an agent would have to go to the manufacturer,
processor, and farm to ensure the purity of the milk.
Supporters of BST labeling say that a scheme of regulated voluntary labeling
could be set up to require certication of BST-free farms and adavits from
those who process BST-free milk. However, there are still enforcement problems.
Since the BST is undetectable, it would be easy for a fraudulent operator to
make false claims. The only way the FDA could ever impose a penalty is if a
farmer was caught red-handed, injecting the BST supplement into a BST-free
cow. It is unrealistic to impose such requirements on FDA agents, since only
1500 inspectors are responsible for the nation's entire supply of food, drugs, and
cosmetics.
Those who support B ST free labeling might argue that the FDA could limit
cases of enforcement to when someone blows the whistle. However, the issue of
one man's word against another's would arise; there is no independent way to
test to determine whether the whistleblower or the farmer/processor is correct.
Label Clutter
Opponents of BST labeling contend that, even if a non-misleading label
could be developed, it would crowd out important messages. 21 A label should
focus on the information that is of the greatest health signicance. Social con-
sciousness messages like BST free are collateral to the main need to provide
nutrition and safety information on a label. Too much clutter on a label leads
to information overload; consumers would take
21Merrill Letter, supra note 7, at 9.
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one look at the massive amount of information on the label and decide to
ignore it all, including the important nutrition information.
These opponents could point to the BST free label developed by the state of
Wisconsin. The Wisconsin label requires that a BST free claim should include
the following statements: I) It is not the policy of the packager or processor
to accept milk or dairy products from cows administered BST, 2) According
to FDA, synthetic BST poses no threat to human health, and 3) There is no
laboratory test that can prove whether synthetic BST has or has not been
used to produce a dairy product.22 Opponents would contend that all these
statements are bewildering to the average consumer.
Proponents of BST labeling would contend that BST labeling is worthwhile
information. Consumers want to know how their products are made; just look
at the interest in organic and natural foods. People may be bewildered about
some things in life (like tax returns), but they are smart when it comes to what
they put in their bodies every day. People will take the time to sort through
label information.
The Consumers' Right to Know
Supporters of BST labeling would vehemently argue that the FDA should
not ban labeling just because it paternalistically thinks consumers would be
confused or misled. Convincing people like Darlene Lynwood that they have
no right to choose B ST-free milk and telling manufacturers that they have
no right to cater to people like Darlene Lynwood by selling BST-free milk is
an infringement upon personal liberty. Proponents contend, Consumers have a
right to know whether BST is used, regardless of whether the
22Letter from Alan T. Tracy, Secretary, State of Wisconsin, Department of
Agriculture, Trade and Consumer Protection to Representative Barbara Grone-
mus, Wisconsin Assembly, Agriculture, Forestry & Rural Aairs Committee 2
(Oct. 8, 1993) (on le with author).
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information is siunicant from the standpoint of product quality, health, or
nutrition.23 Our free market is based on catering to consumers' tastes, regardless
of how sound or logical they may seem; the enormous popularity of pet rocks,
Chia pets, and miracle thigh cream are but a few examples of our free market
at work.
Opponents of BST labeling would argue that, certainly new products can
be developed to cater to customers' tastes, but BST milk is not a new product.
Trying to tell consumers that BST-free milk is dierent from milk with BST is
wrong, as the arguments on misleading claims above indicate.
Eect of Labeling on Consumer Acceptance
Most consumers are currentl not aware of the development of milk from
cows treated with BST. In a survey taken in November, 1993, by the Grocery
Manufacturers Association, more than 80 percent of American households said
they had not heard of BST.24 A similar study by the National Dairy Promotion
& Research Board found that only 7 percent of respondents were aware of issues
relating to BST on an unaided basis.'25 If labels were banned, supporters of BST
use would benet, because many consumers might never nd out about BST.
These consumers would likely just continue buying their regular milk without
realizing it comes from cows injected with synthetic BST. However, if opponents
of BST use wage a successful campaign to make consumers hostile to BST, milk
consumption would drop.
Opponents of BST use say the FDA should allow labeling, so the market
can determine the outcome of BST. Surveys indicate that consumers want to
know when
23~ FA1g~ OF WISCONSIN DEPARTMENT OF AGRICULTURE, TRADE
& CONSUMER
PROTECTION, REGULATION OF SUPPLEMENTAL BOVINE SOMA-
TOTROPIN IN WISCONSIN:
AN EVALUATION OF DAIRY PRODUCT LABELING 1 (March 1991)
[hereinafter WISCONSIN].
24Steven Pratt, Cattle Growth Hormone BST Boosts Milk Production, But
Labeling,
Safely Still ('onceni Some Critics, CHICAGO TRIBUNE, Dec. 16, 1993, at
8A.
25Gail Rosenbaum Doe, The people ~ choice: ('onsumer reaction to bovine
somatotropin; The Realitj.~' of BST, DAIRY FooDs, July 1993, at 44.
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their food is developed using biotechnology. One study showed that 85
percent of consumers said labels indicating use of biotechnoloizy were very
important.26 Another survey of 400 women with milk-drinking children found
an even greater interest in BSTfree milk: [t]wo-thirds of the respondents said
they would change their milk brand in order to get milk that is produced by
BST-free cows27
A government report showed that consumer reactions to BST were based
on the following concerns: 1) a fear of new technology, 2) lack of long term
data, 3) emotional link between milk and children, 4) concerns with animal
cruelty, 5) consumers' right to know, 6) distrust of government. and 7) support
for small scale agriculture.28 The National Dairy Promotion & Research Board
study found that a large majority [of survey respondents], particularly those
with children under 18, reported a fear that ill eects caused by BST would be
discovered in the future.29 Supporters of BST would argue these reactions are
based on emotion rather than science;30 we should not allow such unfounded
fears to hamper scientic development. Opponents of BST would counter that
purchases of every product are based on emotional reactions; to divorce emotions
from science or product development is absurd
JfBST free labeling were allowed, the success or failure of BST would depend
on whether consumers switched to the new milk. This would, in turn, depend on
how much the price of BST-free milk exceeds that of regular milk and whether
consumers would pay the dierential. Given the need to segregate BST-free
herds, it is likely that B ST-free milk could cost substantially more than milk
with BST. There are conicting indications as to whether consumers would pay
the price dierential. A government
2601 FICL 01 MANAGEMENT AND BUDGET, supra note 6, at 42.
27Doe, supra note 25, at 44.
2SOFJ:ICE OF MANAGEMENT AND BUDGET, supra note 6, at 44.
29DoefE supra note 25, at 44.
30Gasparello, supi-a note 17, at I (statement by Vermont Farm Bureau President
Walter
Pyle).
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report indicated that studies done for pesticides show that even though con-
sumers prefer labeling, they are not willing to pay signicantly higher prices to
get labeling.3 I However, the survey of 400 women found that 63 percent of the
women would be willing to pay more for milk that comes from BST-free cows32
Given the unpredictability of demand for BST-free milk, opponents of BST
labeling would argue that the government should not impose labeling and cer-
tication requirements based on such speculative long-term consumer concern.
Unless substantial consumer interest{beyond the speculative interest currently
found{develops, the costs of labeling and of getting milk from a dedicated herd
will outweigh the information benets provided to consumers.33 Supporters of
labeling argue that, if a producer wants to risk developing a product, like BST-
free milk, that may not eventually sell protably, that is the producer's choice.
The FDA should not intervene at this point to ban labeling.
Economic Eects and U.S. Competitiveness
Opponents of BST use are concerned about the eects of BST use on small
farms. BST will depress farm milk prices, and accelerate the trend toward
fewer and larger dairy farms. .. Small farms may not be able to aord the
more sophisticated feeding systems and computerized information systems that
successful adoption of BST may eventually require.34 Labeling should be allowed
so that a market can be developed for BST-free milk supplied by these small
farmers. Giving consumers the opportunity to choose from a variety of products
and to base decisions on a desire to help small farms is the essence of the free
market.
BST supporters counter that FDA's mission is to protect public health and
safety; FDA is not concerned with the socio-economic eects of BST. Since BST
poses no
31U.S. CONGRESS, OFFICE OF TECHNOLOGY ASSESSMENT, supra
note 2, at 333.
32Doe, supra note 25. at 44
33WISCONSIN, supra note 23, at 2.
34CHITE, supra note 14, at 4.
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health threat, BST-free labeling should be banned. Additionally, the FDA
should not interfere with the technological development of the dairy industry to
protect farmers who cannot compete successfully. Our economy is built around
the competitive allocation of resources. Small and large farmers should be ex-
pected to keep up with dairy industry developments; those who lose money
in dairying should shift their assets into a more productive use. Competitive
development is the hallmark of dairying. Improvements in genetics, medicine,
feed and herd management have more than tripled the output per cow and
led to a reduction in the number of U.S. dairy cows of over fty percent since
1955.~~ Even without BST. this structural trend toward fewer and larger farms
will continue.36 Senator Hatch put the issue succinctly: Banning BST because,
although it leads to greater productivity by certain entities, it could nega-
tively aect others is comparable to banning the use of computers because
certain small companies cannot aord to purchase them and they might be
at a disadvantage.37
BST opponents argue there is already an overabundance of milk. Through
its dairy price support program, the government spends millions of dollars an-
nually to buy and store dairy surpluses. Ultimately taxpayers will pick up the
price tag for this development of needless scientic magic; one BST opponent
asked why we should bother to increase the production of a commodity that
already has attained a troublesome level of abundance38
BST supporters counter that scientic development should not be stopped
just because a product is currently plentiful. As a report by the Oce of Tech-
nology Assessment noted, For U.S. agriculture to retain its status it is necessary
to enhance
35Robert Steyer, Will Monsanto~ BST Send Flood of Milk into Supermar-
kets?, ST.
LOUIS POST-DISPATCH, Dec. 6, 1993, at 12.
36C1IITE, supra note 14, at 5.
37Senator Orin Hatch, Remarks to the Senate Radio-TV Gallery, Federal
News Service,
Aug. 3, 1993, in LEXIS, Nexis Library.
38Richard Orr, De.spite FDA Blessing, Farmers Union Calls Bovine Hor-
mone a Bad
Idea, CHICAGO TRIBUNE, Nov. 22, 1993, at 3.
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public and private-sector capacity for scientic research and technology de-
velopment. The costs, to consumers and producers, of failure to maintain and
enhance our eciency tn production would greatly exceed the adjustment costs
resulting from overabundance.39 In addition, biotechnology development needs
to be encouraged The US. biotechnology industry leads the world in the devel-
opment of new products and is something this nation should be proud of The
government should not allow the scare tactics employed by BST opponents to
kill this industry.
CONCLUSION
Niany of the arguments made revolve around the central issue of whether the
market should be allowed to decide the fate of BST or whether overarching con-
cerns dictate that the FDA should intervene to ban BST labeling as inherently
misleading under x201(n) of the Food, Drug, and Cosmetic Act. Government
decisionmakers should constantly consider whether market intervention is jus-
tied.
BST supporters contend the government should intervene to prohibit the
marketing of a false product like BST-free milk. BST opponents argue that
permitting voluntary labeling is the essence of the free market; it allows pro-
ducers and consumers, like Darlene Lynwood, to determine the success or failure
of BST through their pocketbooks. The future of biotechnology should be de-
cided in the open market.
The arguments on both sides of this issue are strong, and I personally could
decide either way (although I am leaning towards supporting FDA's current
policy of voluntary labeling). Although BST has been an issue before the FDA
for almost a decade now, the FDA should not consider the les on this issue
to be closed just because BST will be on the market in a few days. The FDA
should consider further debate into the labeling issue.
39U S CONGRESS, OFFICE OF TECHNOLOGY ASSESSMENT, supra
note 2, at 148-49.
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